{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:50:39Z","timestamp":1788187839066,"version":"build-2803163510"},"reference-count":52,"publisher":"Harborside Press, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Chemotherapy predisposes people who menstruate to abnormal uterine bleeding that can be life-threatening and may also damage ovaries, resulting in premature menopause. The purpose of this study was to explore the incidence of menstrual history documentation and counseling before, during, and after cancer treatment. <jats:bold>Patients and Methods:<\/jats:bold> The medical charts of 137 consecutive females (self-reported) aged 18 to 49 years receiving anticancer treatment at a major tertiary metropolitan hospital in Australia between 2017 and 2020 were reviewed. Data collected included primary diagnosis, stage of cancer, treatment(s) received, rates of remission or progression, documentation of involvement of a specialist gynecologist, reproductive history, menstrual disturbances, menstruation counseling or intervention offered, and diagnosis of early ovarian failure. <jats:bold>Results:<\/jats:bold> Only 16.1% of patients had their menstrual history documented at the initial consult, and 49.6% had their menstrual history documented at a subsequent consult with their treating oncologist or hematologist. Most (82.4%) patients with a menstrual history documented experienced menstrual disturbance posttreatment, most commonly amenorrhea (48.0%), followed by menopause or menopause symptoms (20.6%), irregular menstrual bleeding (16.7%), menorrhagia (13.7%), dysmenorrhea (3.9%), and iron deficiency from bleeding (2.9%). Menopause\/Menopausal symptoms and iron deficiency were more likely to be treated than other disturbances. <jats:bold>Conclusions:<\/jats:bold> Menstruation disturbance is a common side effect of cancer treatment. Menstrual care should be integral to cancer care for people who menstruate, and higher engagement could be achieved through education of medical and allied health staff, information technology systems automating prompts and referral pathways, regular audits to ensure compliance, better alliances between cancer and fertility specialists, and the creation of accessible patient information to promote awareness and facilitate discussion.<\/jats:p>","DOI":"10.6004\/jnccn.2022.7255","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T19:55:49Z","timestamp":1680638149000},"page":"366-372","source":"Crossref","is-referenced-by-count":1,"title":["Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care"],"prefix":"10.6004","volume":"21","author":[{"given":"Verity","family":"Chadwick","sequence":"first","affiliation":[{"name":"Royal North Shore Hospital, St. Leonards, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Kim","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Mills","sequence":"additional","affiliation":[{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Haematology and Flow Cytometry, Laverty Pathology, Macquarie Park, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Anazodo","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"},{"name":"Kids Cancer Centre, Sydney Children\u2019s Hospital, Randwick, Sydney, NSW, Australia"},{"name":"Nelune Cancer Centre, Prince of Wales Hospital, Randwick, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dear","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"},{"name":"Department of Oncology, St Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Rodgers","sequence":"additional","affiliation":[{"name":"Department of Reproductive Medicine, Royal Hospital for Women, Randwick, Sydney, NSW, Australia"},{"name":"School of Women\u2019s and Children\u2019s Health, University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Lavee","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"},{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Milliken","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"},{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"McCaughan","sequence":"additional","affiliation":[{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Moore","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"},{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Withers","sequence":"additional","affiliation":[{"name":"University of New South Wales, Kensington, NSW, Australia"},{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Hamad","sequence":"additional","affiliation":[{"name":"Department of Haematology, Kinghorn Cancer Centre, St. Vincent\u2019s Hospital, Darlinghurst, NSW, Australia"},{"name":"St. Vincent\u2019s Clinical School, University of New South Wales, Sydney, NSW, Australia"},{"name":"School of Medicine, University of Notre Dame, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","article-title":"SEER: cancer stat facts: cancer among adolescents and young adults (AYAs) (ages 15\u201339)","unstructured":"National Cancer Institute. SEER: cancer stat facts: cancer among adolescents and young adults (AYAs) (ages 15\u201339). Accessed February 1, 2022. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/aya.html"},{"key":"B2","article-title":"Book 1a - cancer incidence (age-standardised rates and 5-year age groups)","unstructured":"Australian Institute of Health and Welfare. Book 1a - cancer incidence (age-standardised rates and 5-year age groups). Accessed February 1, 2022. Available at: https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/data"},{"key":"B3","series-title":"J Adolesc Young Adult Oncol","first-page":"23","article-title":"Experiences with menses and menstrual suppression of young women with a history of cancer","volume":"9","author":"Close AG","year":"2020","unstructured":"Close AG, Ghuman A, Friehling E,  Experiences with menses and menstrual suppression of young women with a history of cancer. J Adolesc Young Adult Oncol 2020;9:23\u201329.31592736"},{"key":"B4","series-title":"Lymphoma","first-page":"952698","article-title":"Therapy-related late adverse events in Hodgkin\u2019s lymphoma","volume":"2013","author":"Gotti M","year":"2013","unstructured":"Gotti M, Fiaccadori V, Bono E,  Therapy-related late adverse events in Hodgkin\u2019s lymphoma. Lymphoma 2013;2013:952698."},{"key":"B5","series-title":"Pediatr Blood Cancer","first-page":"e27961","article-title":"Current practices in menstrual management in adolescents with cancer: a national survey of pediatric oncology providers","volume":"66","author":"Close AG","year":"2019","unstructured":"Close AG, Jones KA, Landowski A,  Current practices in menstrual management in adolescents with cancer: a national survey of pediatric oncology providers. Pediatr Blood Cancer 2019;66:e27961."},{"key":"B6","series-title":"Reprod Sci","first-page":"939","article-title":"Gonadotropin-releasing hormone analogs for gonadal protection during gonadotoxic chemotherapy: a systematic review and meta-analysis","volume":"26","author":"Sofiyeva N","year":"2019","unstructured":"Sofiyeva N, Siepmann T, Barlinn K,  Gonadotropin-releasing hormone analogs for gonadal protection during gonadotoxic chemotherapy: a systematic review and meta-analysis. Reprod Sci 2019;26:939\u2013953.30270741"},{"key":"B7","series-title":"Fertil Steril","first-page":"1214","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"100","year":"2013","unstructured":"Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril 2013;100:1214\u20131223."},{"key":"B8","article-title":"Menorrhagia","author":"Walker MH","unstructured":"Walker MH, Coffey W, Borger J. Menorrhagia. Accessed February 1, 2022. Available at: https:\/\/www.statpearls.com\/point-of-care\/24986"},{"key":"B9","series-title":"JNCI Cancer Spectr","first-page":"pkz008","article-title":"Cancer treatment-related infertility: a critical review of the evidence","volume":"3","author":"Poorvu PD","year":"2019","unstructured":"Poorvu PD, Frazier AL, Feraco AM,  Cancer treatment-related infertility: a critical review of the evidence. JNCI Cancer Spectr 2019;3:pkz008.31360893"},{"key":"B10","series-title":"Fertil Steril","first-page":"765","article-title":"Menses resumption after cancer treatment\u2013induced amenorrhea occurs early or not at all","volume":"105","author":"Jacobson MH","year":"2016","unstructured":"Jacobson MH, Mertens AC, Spencer JB,  Menses resumption after cancer treatment\u2013induced amenorrhea occurs early or not at all. Fertil Steril 2016;105:765\u2013772.E4.26658130"},{"key":"B11","series-title":"Front Endocrinol (Lausanne)","first-page":"612042","article-title":"Oligo\/Amenorrhea is an independent risk factor associated with low ovarian response","volume":"12","author":"Hu KL","year":"2021","unstructured":"Hu KL, Gan K, Ying Y,  Oligo\/Amenorrhea is an independent risk factor associated with low ovarian response. Front Endocrinol (Lausanne) 2021;12:612042.34177795"},{"key":"B12","series-title":"Leuk Lymphoma","first-page":"1616","article-title":"Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas","volume":"57","author":"Gharwan H","year":"2016","unstructured":"Gharwan H, Lai C, Grant C,  Female fertility following dose-adjusted EPOCH-R chemotherapy in primary mediastinal B-cell lymphomas. Leuk Lymphoma 2016;57:1616\u20131624.27183887"},{"key":"B13","series-title":"Acta Oncol","first-page":"664","article-title":"Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis","volume":"55","author":"Zavos A","year":"2016","unstructured":"Zavos A, Valachis A. Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis. Acta Oncol 2016;55:664\u2013670.27105082"},{"key":"B14","series-title":"Bone Marrow Transplant","first-page":"1551","article-title":"Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 years","volume":"50","author":"Akhtar S","year":"2015","unstructured":"Akhtar S, Youssef I, Soudy H,  Prevalence of menstrual cycles and outcome of 50 pregnancies after high-dose chemotherapy and auto-SCT in non-Hodgkin and Hodgkin lymphoma patients younger than 40 years. Bone Marrow Transplant 2015;50:1551\u20131556.26237168"},{"key":"B15","series-title":"J Clin Oncol","first-page":"1981","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini M","year":"2018","unstructured":"Lambertini M, Moore HC, Leonard R,  Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data. J Clin Oncol 2018;36:1981\u20131990.29718793"},{"key":"B16","series-title":"Int J Gynaecol Obstet","first-page":"3","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro MG","year":"2011","unstructured":"Munro MG, Critchley HO, Broder MS,  FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011;113:3\u201313.21345435"},{"key":"B17","article-title":"Heavy menstrual bleeding (HMB)","unstructured":"Queensland Government, Metro South Health. Heavy menstrual bleeding (HMB). Accessed February 1, 2022. Available at: https:\/\/metrosouth.health.qld.gov.au\/referrals\/gynaecology\/heavy-menstrual-bleeding"},{"key":"B18","series-title":"J Oncol Pract","first-page":"137","article-title":"If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients\u2019 medical records","volume":"11","author":"Quinn GP","year":"2015","unstructured":"Quinn GP, Block RG, Clayman ML,  If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients\u2019 medical records. J Oncol Pract 2015;11:137\u2013144."},{"key":"B19","series-title":"Fem Psychol","first-page":"337","article-title":"\u201cDo mad people get endo or does endo make you mad?\u201d: clinicians\u2019 discursive constructions of Medicine and women with endometriosis","volume":"29","author":"Young K","year":"2019","unstructured":"Young K, Fisher J, Kirkman M. \u201cDo mad people get endo or does endo make you mad?\u201d: clinicians\u2019 discursive constructions of Medicine and women with endometriosis. Fem Psychol 2019;29:337\u2013356."},{"key":"B20","series-title":"Hum Reprod Update","first-page":"748","article-title":"Menstrual physiology: implications for endometrial pathology and beyond","volume":"21","author":"Maybin JA","year":"2015","unstructured":"Maybin JA, Critchley HO. Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update 2015;21:748\u2013761.26253932"},{"key":"B21","series-title":"Am J Obstet Gynecol","first-page":"617","article-title":"Revisiting menstruation: the misery, mystery, and marvel","volume":"223","author":"Tingen CM","year":"2020","unstructured":"Tingen CM, Halvorson LM, Bianchi DW. Revisiting menstruation: the misery, mystery, and marvel. Am J Obstet Gynecol 2020;223:617\u2013618.32709301"},{"key":"B22","article-title":"Ending period \u2018taboo\u2019 gave USA marginal gain at World Cup","author":"Pender K","unstructured":"Pender K. Ending period \u2018taboo\u2019 gave USA marginal gain at World Cup. The Telegraph. July 13, 2019. Accessed February 1, 2022. Available at: https:\/\/www.telegraph.co.uk\/world-cup\/2019\/07\/13\/revealed-next-frontier-sports-science-usas-secret-weapon-womens\/"},{"key":"B23","series-title":"Pediatrics","first-page":"2245","article-title":"Menstruation in girls and adolescents: using the menstrual cycle as a vital sign","volume":"118","author":"Diaz A","year":"2006","unstructured":"Diaz A, Laufer MR, Breech LL,  Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Pediatrics 2006;118:2245\u20132250.17079600"},{"key":"B24","series-title":"Obstet Gynecol","first-page":"e143","article-title":"ACOG committee opinion no. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign","volume":"126","year":"2015","unstructured":"Committee on Adolescent Health Care. ACOG committee opinion no. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 2015;126:e143\u2013146.26595586"},{"key":"B25","series-title":"Hum Reprod","first-page":"1281","article-title":"The impact of cancer on subsequent chance of pregnancy: a population-based analysis","volume":"33","author":"Anderson RA","year":"2018","unstructured":"Anderson RA, Brewster DH, Wood R,  The impact of cancer on subsequent chance of pregnancy: a population-based analysis. Hum Reprod 2018;33:1281\u20131290.29912328"},{"key":"B26","series-title":"JBRA Assist Reprod","first-page":"418","article-title":"Fertility optimization in women with cancer: from preservation to contraception","volume":"23","author":"Melo AS","year":"2019","unstructured":"Melo AS, Paula CTV, Rufato MAF,  Fertility optimization in women with cancer: from preservation to contraception. JBRA Assist Reprod 2019;23:418\u2013429.30969739"},{"key":"B27","series-title":"Support Care Cancer","first-page":"4451","article-title":"Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis","volume":"27","author":"Gerstl B","year":"2019","unstructured":"Gerstl B, Sullivan E, Koch J,  Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis. Support Care Cancer 2019;27:4451\u20134460.31541306"},{"key":"B28","series-title":"Hum Reprod Update","first-page":"161","article-title":"Do cancer therapies damage the uterus and compromise fertility?","volume":"26","author":"Griffiths MJ","year":"2020","unstructured":"Griffiths MJ, Winship AL, Hutt KJ. Do cancer therapies damage the uterus and compromise fertility? Hum Reprod Update 2020;26:161\u2013173.31863097"},{"key":"B29","series-title":"Reprod Biomed Online","first-page":"712","article-title":"Five-year study assessing the clinical utility of anti-M\u00fcllerian hormone measurements in reproductive-age women with cancer","volume":"39","author":"Palinska-Rudzka KE","year":"2019","unstructured":"Palinska-Rudzka KE, Ghobara T, Parsons N,  Five-year study assessing the clinical utility of anti-M\u00fcllerian hormone measurements in reproductive-age women with cancer. Reprod Biomed Online 2019;39:712\u2013720.31471141"},{"key":"B30","series-title":"Obstet Gynecol","first-page":"e7","article-title":"Options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment: ACOG committee opinion, number 817","volume":"137","year":"2021","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Adolescent Health Care. Options for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment: ACOG committee opinion, number 817. Obstet Gynecol 2021;137:e7\u201315.33399429"},{"key":"B31","series-title":"J Adolesc Young Adult Oncol","first-page":"431","article-title":"Depression and health-related quality of life among young adult breast cancer patients: the mediating role of reproductive concerns","volume":"9","author":"B\u00e1rtolo A","year":"2020","unstructured":"B\u00e1rtolo A, Santos IM, Val\u00e9rio E,  Depression and health-related quality of life among young adult breast cancer patients: the mediating role of reproductive concerns. J Adolesc Young Adult Oncol 2020;9:431\u2013435."},{"key":"B32","series-title":"J Midwifery Womens Health","first-page":"713","article-title":"Long\u2010term effects of breast cancer surgery, treatment, and survivor care","volume":"64","author":"Lovelace DL","year":"2019","unstructured":"Lovelace DL, McDaniel LR, Golden D. Long\u2010term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health 2019;64:713\u2013724.31322834"},{"key":"B33","series-title":"Yen and Jaffe\u2019s Reproductive Endocrinology","first-page":"556","article-title":"Female infertility","author":"Barbieri R","year":"2017","unstructured":"Barbieri R. Female infertility. In: Strauss J, Barbieri R, eds. Yen and Jaffe\u2019s Reproductive Endocrinology. 8th ed. Elsevier; 2017:556\u2013581."},{"key":"B34","series-title":"Eur J Haematol","first-page":"137","article-title":"Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies","volume":"93","author":"Naess\u00e9n S","year":"2014","unstructured":"Naess\u00e9n S, Bergstr\u00f6m I, Ljungman P,  Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies. Eur J Haematol 2014;93:137\u2013142.24649942"},{"key":"B35","series-title":"Pathol Oncol Res","first-page":"63","article-title":"Hormone replacement therapy in cancer survivors: review of the literature","volume":"26","author":"Deli T","year":"2020","unstructured":"Deli T, Orosz M, Jakab A. Hormone replacement therapy in cancer survivors: review of the literature. Pathol Oncol Res 2020;26:63\u201378.30617760"},{"key":"B36","series-title":"Medicina (Kaunas)","first-page":"573","article-title":"Current evidence of the oncological benefit-risk profile of hormone replacement therapy","volume":"55","author":"D\u2019Alonzo M","year":"2019","unstructured":"D\u2019Alonzo M, Bounous VE, Villa M,  Current evidence of the oncological benefit-risk profile of hormone replacement therapy. Medicina (Kaunas) 2019;55:573.31500261"},{"key":"B37","series-title":"Climacteric","first-page":"3","article-title":"Hormone replacement therapy - where are we now?","volume":"24","author":"Langer RD","year":"2021","unstructured":"Langer RD, Hodis HN, Lobo RA,  Hormone replacement therapy - where are we now? Climacteric 2021;24:3\u201310.33403881"},{"key":"B38","series-title":"J Assist Reprod Genet","first-page":"325","article-title":"Fertility in young patients following treatment for Hodgkin\u2019s lymphoma: a single center survey","volume":"33","author":"Bolte\u017ear L","year":"2016","unstructured":"Bolte\u017ear L, Pintari\u0107 K, Jezer\u0161ek Novakovi\u0107 B. Fertility in young patients following treatment for Hodgkin\u2019s lymphoma: a single center survey. J Assist Reprod Genet 2016;33:325\u2013333.26678493"},{"key":"B39","series-title":"Pediatr Blood Cancer","first-page":"e27087","article-title":"Barriers and facilitators to sexual and reproductive health communication between pediatric oncology clinicians and adolescent and young adult patients: the clinician perspective","volume":"65","author":"Frederick NN","year":"2018","unstructured":"Frederick NN, Campbell K, Kenney LB,  Barriers and facilitators to sexual and reproductive health communication between pediatric oncology clinicians and adolescent and young adult patients: the clinician perspective. Pediatr Blood Cancer 2018;65:e27087."},{"key":"B40","article-title":"Abnormal pain and menstrual bleeding\u2014heavy menstrual bleeding (HMB) overview","unstructured":"The Society of Obstetricians and Gynaecologists of Canada. Abnormal pain and menstrual bleeding\u2014heavy menstrual bleeding (HMB) overview. Accessed January 11, 2021. Available at: https:\/\/www.yourperiod.ca\/abnormal-pain-and-menstrual-bleeding\/heavy-menstrual-bleeding\/"},{"key":"B41","series-title":"J Obstet Gynaecol Can","first-page":"e391","article-title":"No. 292\u2014abnormal uterine bleeding in pre-menopausal women","volume":"40","author":"Singh S","year":"2018","unstructured":"Singh S, Best C, Dunn S,  No. 292\u2014abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can 2018;40:e391\u2013415.29731212"},{"key":"B42","series-title":"Kidney Int Rep","first-page":"152","article-title":"Female reproductive and gynecologic considerations in Chronic kidney disease: adolescence and young adulthood","volume":"7","author":"Chang DH","year":"2022","unstructured":"Chang DH, Dumanski SM, Ahmed SB. Female reproductive and gynecologic considerations in Chronic kidney disease: adolescence and young adulthood. Kidney Int Rep 2022;7:152\u2013164."},{"key":"B43","series-title":"BMC Med Inform Decis Mak","first-page":"107","article-title":"Improving the effectiveness of electronic health record-based referral processes","volume":"12","author":"Esquivel A","year":"2012","unstructured":"Esquivel A, Sittig DF, Murphy DR,  Improving the effectiveness of electronic health record-based referral processes. BMC Med Inform Decis Mak 2012;12:107.22973874"},{"key":"B44","series-title":"Pediatrics","first-page":"e20153410","article-title":"Innovative use of the electronic health record to support harm reduction efforts","volume":"139","author":"Hyman D","year":"2017","unstructured":"Hyman D, Neiman J, Rannie M,  Innovative use of the electronic health record to support harm reduction efforts. Pediatrics 2017;139:e20153410.28557714"},{"key":"B45","series-title":"J Natl Compr Canc Netw","first-page":"71","article-title":"Optimizing fertility preservation practices for adolescent and young adult cancer patients","volume":"11","author":"Johnson RH","year":"2013","unstructured":"Johnson RH, Kroon L. Optimizing fertility preservation practices for adolescent and young adult cancer patients. J Natl Compr Canc Netw 2013;11:71\u201377."},{"key":"B46","series-title":"J Oncol Pract","first-page":"303","article-title":"Implementing a systematic approach to meeting patients\u2019 cancer and fertility needs: a review of the Fertile Hope Centers Of Excellence program","volume":"8","author":"Reinecke JD","year":"2012","unstructured":"Reinecke JD, Kelvin JF, Arvey SR,  Implementing a systematic approach to meeting patients\u2019 cancer and fertility needs: a review of the Fertile Hope Centers Of Excellence program. J Oncol Pract 2012;8:303\u2013308."},{"key":"B47","series-title":"J Urol","first-page":"979","article-title":"Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program","volume":"187","author":"Sheth KR","year":"2012","unstructured":"Sheth KR, Sharma V, Helfand BT,  Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program. J Urol 2012;187:979\u2013986.22264454"},{"key":"B48","series-title":"PLoS One","first-page":"e0248677","article-title":"Understanding how and why audits work in improving the quality of hospital care: a systematic realist review","volume":"16","author":"Hut-Mossel L","year":"2021","unstructured":"Hut-Mossel L, Ahaus K, Welker G,  Understanding how and why audits work in improving the quality of hospital care: a systematic realist review. PLoS One 2021;16:e0248677."},{"key":"B49","series-title":"Support Care Cancer","first-page":"3353","article-title":"Cancer and fertility preservation in Puerto Rico: a qualitative study of healthcare provider perceptions","volume":"24","author":"Dyer KE","year":"2016","unstructured":"Dyer KE, Quinn GP. Cancer and fertility preservation in Puerto Rico: a qualitative study of healthcare provider perceptions. Support Care Cancer 2016;24:3353\u20133360.26980331"},{"key":"B50","series-title":"Support Care Cancer","first-page":"3191","article-title":"Young female cancer survivors\u2019 use of fertility care after completing cancer treatment","volume":"24","author":"Kim J","year":"2016","unstructured":"Kim J, Mersereau JE, Su HI,  Young female cancer survivors\u2019 use of fertility care after completing cancer treatment. Support Care Cancer 2016;24:3191\u20133199.26939923"},{"key":"B51","series-title":"Psychooncology","first-page":"459","article-title":"Systematic review of fertility preservation patient decision aids for cancer patients","volume":"28","author":"Wang Y","year":"2019","unstructured":"Wang Y, Anazodo A, Logan S. Systematic review of fertility preservation patient decision aids for cancer patients. Psychooncology 2019;28:459\u2013467.30523651"},{"key":"B52","series-title":"J Am Med Inform Assoc","first-page":"144","article-title":"Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research","volume":"20","author":"Weiskopf NG","year":"2013","unstructured":"Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc 2013;20:144\u2013151.22733976"}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/21\/4\/article-p366.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/21\/4\/article-p366.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/21\/4\/article-p366.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:35:07Z","timestamp":1689104107000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/21\/4\/article-p366.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":52,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2022.7255","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]}}}